AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

TherapeuticsMD, Inc. Director's Dealing 2012

Mar 2, 2012

35134_dirs_2012-03-02_fa5143fb-4fc7-4da9-9470-088294ea83d4.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2012-02-29

Reporting Person: LaPenta Robert V Jr (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	5000	Direct